Drugs, Non-Prescription
Showing 26 - 50 of >10,000
Implementation and Evaluation of SBIRT
Completed
- Substance Use Disorders
- SBIRT Training and Implementation Strategies
-
Indianapolis, IndianaIndiana University
May 3, 2020
Non Small Cell Lung Cancer, Secondary Lung Cancer Trial in Salt Lake City (Personalized Exercise Program)
Completed
- Non Small Cell Lung Cancer
- Secondary Lung Cancer
- Personalized Exercise Program
-
Salt Lake City, UtahHuntsman Cancer Institute
Aug 9, 2022
Hypertension, Hypertension,Essential Trial (fixed-dose of olmesartan 20mg/40 mg + indapamide 1,5 mg, Isolated drugs Olmesartan
Not yet recruiting
- Hypertension
- Hypertension,Essential
- fixed-dose of olmesartan 20mg/40 mg + indapamide 1,5 mg
- Isolated drugs Olmesartan (20 mg or 40 mg) and Indapamide (1,5 mg)
- (no location specified)
Mar 17, 2022
Hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in Aurora (Inspiratory muscle strength training, Sham Inspiratory muscle strength
Not yet recruiting
- Hodgkin Lymphoma
- Non Hodgkin Lymphoma
- Inspiratory muscle strength training
- Sham Inspiratory muscle strength training
-
Aurora, Colorado
- +1 more
Jun 30, 2023
Maculopathy Trial in Assiut (non steroidal anti inflammatory drugs)
Not yet recruiting
- Maculopathy
- non steroidal anti inflammatory drugs
-
Assiut, Egypt
- +1 more
Jan 8, 2023
Coronary Artery Disease, Acute Myocardial Infarction, Coronary Artery Stenosis Trial in Saskatoon (De-prescribe beta blocker
Recruiting
- Coronary Artery Disease
- +4 more
- De-prescribe beta blocker therapy
-
Saskatoon, Saskatchewan, CanadaRoyal University Hospital
Sep 27, 2021
TB Drugs and Bacterial Drug Resistance
Completed
- Tuberculosis
- Non-Tuberculosis Mycobacteria
-
Bethesda, Maryland
- +1 more
Mar 25, 2022
Osteoarthritis, Knee Trial in Chicago (Naproxen 500 Mg, Placebo)
Not yet recruiting
- Osteoarthritis, Knee
- Naproxen 500 Mg
- Placebo
-
Chicago, IllinoisNorthwestern University Feinberg School of Medicine
Jun 18, 2022
Bone Resorption, Stress Fracture, Bone Injury Trial in Natick (Ibuprofen 800 mg, Celecoxib 200mg, Flurbiprofen 100 mg)
Recruiting
- Bone Resorption
- +2 more
- Ibuprofen 800 mg
- +3 more
-
Natick, MassachusettsUnited States Army Research Institute of Environmental Medicine
Aug 19, 2022
Lung Diseases, Total Intravenous Anesthesia, Bronchoscopic Interventions Trial in Taipei (bronchoscopic insertion)
Recruiting
- Lung Diseases
- +2 more
- bronchoscopic insertion
-
Taipei, TaiwanNational Taiwan University Cancer Center Hospital
Nov 16, 2022
Preeclampsia Severe, Preeclampsia Postpartum Trial in Saint Louis (Ibuprofen 600 mg, Ketorolac, Acetaminophen)
Recruiting
- Preeclampsia Severe
- Preeclampsia Postpartum
- Ibuprofen 600 mg
- +3 more
-
Saint Louis, MissouriBarnes Jewish Hospital
Oct 12, 2021
Rhinoplasty, Non-steroidal Ant Inflammatory Drugs, Opioid Use Trial in New York (Norco, NSAID)
Completed
- Rhinoplasty
- +2 more
-
New York, New YorkNYU Langone Medical Center
Oct 25, 2021
Non-Alcoholic Fatty Liver Disease, Metabolic Syndrome Trial in New Delhi (IHPD, Western Diet)
Recruiting
- Non-Alcoholic Fatty Liver Disease
- Metabolic Syndrome
- IHPD
- Western Diet
-
New Delhi, Delhi, IndiaInstitute of Liver and Biliary Sciences
Jan 14, 2023
INTERCEPTOR Project: From MCI to Dementia
Active, not recruiting
- Mild Cognitive Impairment
- Alzheimer Disease
-
Rome, ItalyPoliclinico Agostino Gemelli
Aug 2, 2021
NSCLC Trial in Jinan (DZD9008 and Probe drugs (midazolam, digoxin, rosuvastatin))
Recruiting
- Non-small Cell Lung Cancer
- DZD9008 and Probe drugs (midazolam, digoxin, rosuvastatin)
-
Jinan, Shandong, ChinaShandong Cancer Hospital (Shandong Provincial Institute of Cance
Jun 22, 2023
Malaria, Dengue, Influenza -Like Illness Trial in Senegal (Patient clinical management based on the CDSA strategy)
Recruiting
- Malaria
- +5 more
- Patient clinical management based on the CDSA strategy
-
Fatick, Senegal
- +3 more
Oct 26, 2021
Acute Respiratory Tract Infections Trial in Spain (Communication skills training, Mobile phone application on RTI)
Recruiting
- Acute Respiratory Tract Infections
- Communication skills training
- Mobile phone application on RTI
-
Pasaia, Gipuzkoa, Spain
- +3 more
Mar 15, 2022
Acute Pancreatitis in Type 2 Diabetes Mellitus Treated With
Active, not recruiting
- Diabetes Mellitus, Type 2
- empagliflozin
- Oral non-incretin/non-sodium glucose co-transporter-2 inhibitors (SGLT2)-containing hypoglycaemic agents
-
Ingelheim am Rhein, GermanyBoehringer Ingelheim International GmbH
Aug 19, 2022
Recurrent DLBCL Germinal Center B-Cell Type, Recurrent Lymphoma, Recurrent Transformed Non-Hodgkin Lymphoma Trial (Belinostat,
Not yet recruiting
- Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
- +5 more
- Belinostat
- +2 more
- (no location specified)
Dec 2, 2022
Hepatitis C Trial in Sydney (HCV RNA Point of Care, Sofosbuvir/velpatasvir, Glecaprevir/pibrentasvir)
Recruiting
- Hepatitis C
- HCV RNA Point of Care
- +2 more
-
Sydney, New South Wales, AustraliaNUAA NSP
Aug 19, 2022
Pericarditis Acute Trial in Petach Tikva (Dexamethasone therapy, NSAID therapy)
Recruiting
- Pericarditis Acute
- Dexamethasone therapy
- NSAID therapy
-
Petach Tikva, IsraelRabin Medical Center
Sep 30, 2021
Relapsed or Advanced NSCLC Trial (Almonertinib combined with SHR-1701, Almonertinib)
Not yet recruiting
- Relapsed or Advanced Non-small Cell Lung Cancer
- Almonertinib combined with SHR-1701
- Almonertinib
- (no location specified)
Aug 16, 2022
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, drug, biological)
Not yet recruiting
- Recurrent Lung Non-Small Cell Carcinoma
- Stage IV Lung Cancer AJCC v8
- Biospecimen Collection
- +5 more
- (no location specified)
Nov 30, 2022